Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1YA-1011件: YA-101---1件: 17 💬
2YAM80----1件: 2 💬
3Yarrowia lipolytica lipase----1件: 298 💬
4YCJ-01 Full Spectrum cannbis Extract----1件: 158 💬
5Yeast1件: Yeast1件: Dried yeast 💬 --2件: 97, 113 💬
6Yellow fever vaccine1件: Yellow fever vaccine1件: Yellow fever vaccine 💬 --8件: 40, 44, 46, 50, 51, 52, 53, 107 💬
7Yellow Fever vaccine (17D)1件: Yellow fever vaccine1件: Yellow fever vaccine 💬 --8件: 40, 44, 46, 50, 51, 52, 53, 107 💬
8Yi Qi Yang Yin Decoction----1件: 53 💬
9Yiqi Yangyin Formula----1件: 53 💬
10Yisaipu1件: Yisaipu---2件: 46, 271 💬
11Yisaipu®1件: Yisaipu---1件: 271 💬
12YISAIPU® ( An etanercept biosimilar)2件: Etanercept,
Yisaipu		1件: Etanercept 💬 2件: LTA,
TNF 💬 		66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
13Yishen Daluo Yin granuls----1件: 13 💬
14YK012----2件: 49, 222 💬
15YKP509----1件: 144 💬
16YKST02----2件: 49, 66 💬
17YLB113----1件: 46 💬
18YM672----1件: 226 💬
19YM672 (IPD®)----1件: 226 💬
20Yohimbine1件: Yohimbine2件: Yohimbine hydrochloride ,
Yohimbine 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
21Yohimbine HCl1件: Yohimbine2件: Yohimbine hydrochloride ,
Yohimbine 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
22YOLT-101----1件: 79 💬
23YOLT-201----1件: 28 💬
24YOLT-202----1件: 231 💬
25YOLT-203----1件: 234 💬
26YONDELIS 0,25 mg polvo para concentrado para solución para perfusión----1件: 159 💬
27Yondelis 0.25 mg powder for concentrate for solution for infusion.----1件: 159 💬
28YONDELIS 1 mg polvo para concentrado para solución para perfusión----1件: 159 💬
29Yondelis 1 mg powder for concentrate for solution for infusion.----1件: 159 💬
30YRA-1909 high dose----1件: 46 💬
31YRA-1909 low dose----1件: 46 💬
32YRA-1909 mid dose----1件: 46 💬
33YTB323----1件: 49 💬
34YTS109----1件: 61 💬
35YTS109 cell----6件: 46, 48, 49, 51, 53, 61 💬
36YTS109 cell injection----2件: 49, 63 💬
37Yttrium-90 radiolabelled anti-CD66 antibody----1件: 28 💬
38Yttrium­90 radiolabelled anti­CD66----1件: 28 💬
39Yu-Shen formula----1件: 224 💬
40Yuxuebi tablet----1件: 271 💬